In Vivo and In Silico Evidence: Hippocampal Cholesterol Metabolism Decreases with Aging and Increases with Alzheimers Disease - Modeling Brain Aging and Disease. - Clyde F. Phelix; Richard G. LeBaron; Dawnlee J. Roberson; Rosa E. Villanueva; Greg Villareal; Omid B. Rahimi; Sandra Siedlak; Xiongwei Zhu; George Perry (ICDM Workshops, 2011)

Transcriptome-To-Metabolome™ Biosimulation Reveals Human Hippocampal Hypometabolism with Age and Alzheimer's Disease. - Clyde F. Phelix; Richard G. LeBaron; Dawnlee J. Roberson; Rosa E. Villanueva; Greg Villareal; Omid B. Rahimi; Sandra Siedlak; Xiongwei Zhu; George Perry (Int. J. Knowl. Discov. Bioinform., 2011)

Biomarkers from biosimulations: Transcriptome-to-reactome™ Technology for individualized medicine. - Clyde F. Phelix; Greg Villareal; Richard G. LeBaron; Dawnlee J. Roberson (EMBC, 2014)

In Silico Biosimulation of Isoflurane Effects on Brain Using Transcriptome-To-Metabolome™ Technology: Anesthesia Effects on Rat Amygdala & Cortex Metabolism. - Allen K. Bourdon; Clyde F. Phelix (Int. J. Knowl. Discov. Bioinform., 2015)

Low Dose Pioglitazone Attenuates Oxidative Damage in Early Alzheimer's Disease by Binding mitoNEET: Transcriptome-To-Reactome™ Biosimulation of Neurons. - Charles D. Hammack; George Perry; Richard G. LeBaron; Greg Villareal; Clyde F. Phelix (Int. J. Knowl. Discov. Bioinform., 2015)

Integrating information on genomics, transcriptomics, proteomics, and metabolomics into biosimulations for individualized personalized medicine. - Clyde F. Phelix; Jason L. Dugan (BHI, 2016)

Modeling non-clinical and clinical drug tests in Gaucher disease. - Clyde F. Phelix; Allen K. Bourdon; Greg Villareal; Richard G. LeBaron (EMBC, 2016)

Integrating -omics information with biosimulations to assist diagnosis and treatment of diabetes mellitus in silico. - Clyde F. Phelix; Greg Villareal; Richard G. LeBaron; Dawnlee J. Roberson (BHI, 2017)

Alzheimer's and Parkinson's Disease Novel Therapeutic Target: The Mitochondrial Pyruvate Carrier - Ligand Docking to Screen Natural Compounds Related to Classic Inhibitors. - Allen K. Bourdon; Greg Villareal; George Perry; Clyde F. Phelix (Int. J. Knowl. Discov. Bioinform., 2017)

Mitochondrial Pyruvate Carrier 1 and 2 Heterodimer, In Silico, Models of Plant and Human Complexes: A Comparison of Structure and Transporter Binding Properties. - Jason L. Dugan; Allen K. Bourdon; Clyde F. Phelix (Int. J. Knowl. Discov. Bioinform., 2017)

MSDC-0160 and MSDC-0602 Binding with Human Mitochondrial Pyruvate Carrier (MPC) 1 and 2 Heterodimer: PPARγ Activating and Sparing TZDs as Therapeutics. - Clyde F. Phelix; Allen K. Bourdon; Jason L. Dugan; Greg Villareal; George Perry (Int. J. Knowl. Discov. Bioinform., 2017)

Structural Insights into the Human Mitochondrial Pyruvate Carrier Complexes. - Liang Xu; Clyde F. Phelix; Liao Y. Chen (J. Chem. Inf. Model., 2021)